{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/back-pain-low-without-radiculopathy/prescribing-information/diazepam/","result":{"pageContext":{"chapter":{"id":"53da469c-6c3c-5af5-b251-e252f8f3ae47","slug":"diazepam","fullItemName":"Diazepam","depth":2,"htmlHeader":"<!-- begin field 7c36eae4-9076-4a3f-8fa7-0da53295935a --><h2>Diazepam</h2><!-- end field 7c36eae4-9076-4a3f-8fa7-0da53295935a -->","summary":"","htmlStringContent":"<!-- begin item 83405a53-6b8e-4cf1-baa7-a57ab9c8f6dd --><!-- end item 83405a53-6b8e-4cf1-baa7-a57ab9c8f6dd -->","topic":{"id":"67ec8276-483f-5bd3-a1d4-abc190687cec","topicId":"9b18de7f-5dbf-47fa-b614-8130c5721d6c","topicName":"Back pain - low (without radiculopathy)","slug":"back-pain-low-without-radiculopathy","lastRevised":"Last revised in November 2020","chapters":[{"id":"d8279135-bdfb-5f8d-a638-9f5c15e8e31e","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"94f53f0f-68b9-57d2-bb9b-9205b4128d2a","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"1e14b540-8ee6-5ec6-a360-b55991b947f3","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"6ce99d9d-152d-5b24-87b1-279f7cca5449","slug":"changes","fullItemName":"Changes"},{"id":"98f67efe-dc7d-5678-ad87-be8f6369b281","slug":"update","fullItemName":"Update"}]},{"id":"4fa9a83d-808c-53a6-95a7-4906ba0762b3","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"3b4be10b-9039-5c16-9f5c-e53279f4ef3a","slug":"goals","fullItemName":"Goals"},{"id":"ac362b69-f985-5883-8d14-7b25b4cd4c92","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"1581e495-09a8-5389-a60c-1a3b417b8be7","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"5ffd119a-f7fe-5e5d-9891-d3e921d92d40","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"b051c066-56d4-5c85-8b28-98014a97b749","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"302a3eb3-4a2b-550a-89a6-cd26e0eef14a","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"bd777de4-3ef6-529d-bcbf-8bf6aa892e99","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"2e9191b9-9306-5480-be62-c1f812b84b32","slug":"definition","fullItemName":"Definition"},{"id":"810863bb-72c6-58eb-bb75-3e2f1ee214b2","slug":"prevalence","fullItemName":"Prevalence"},{"id":"b2234c07-e852-5713-8078-e978d40b2b82","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"16569068-7bdd-5aad-b47c-7e935d6c6254","slug":"prognosis","fullItemName":"Prognosis"},{"id":"a40462ae-8085-5573-a267-170ee6539bbb","slug":"complications","fullItemName":"Complications"}]},{"id":"140fe6e6-d5e6-56f6-a4ac-d1791b9a1de1","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"6540e013-bdca-57be-8415-3dacd0fd448a","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"b2bb39a7-3f14-593c-a0bb-11b6229e9193","slug":"red-flag-symptoms-signs","fullItemName":"Red flag symptoms and signs"}]},{"id":"41781ac6-3970-5128-9f67-8103d95876c0","fullItemName":"Management","slug":"management","subChapters":[{"id":"1d96563b-1a08-575c-a108-6e566028123f","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"18c68aea-1807-5bbb-a514-d9f773a881fb","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"53da469c-6c3c-5af5-b251-e252f8f3ae47","slug":"diazepam","fullItemName":"Diazepam"},{"id":"e815c8fc-c6d6-5168-aacd-92b8545caf45","slug":"nonsteroidal-anti-inflammatory-drugs","fullItemName":"Nonsteroidal anti-inflammatory drugs"},{"id":"9aaa155a-4c14-58c4-a24d-a0d7594586c1","slug":"paracetamol","fullItemName":"Paracetamol"},{"id":"f098cbb6-72ba-503d-b622-a02915fe6668","slug":"weak-opioids","fullItemName":"Weak opioids"}]},{"id":"9607837f-245f-5649-86a7-425a90fe7c11","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"c264a034-a901-521f-83d9-6e19cfe6295a","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"12ec6fad-43c6-5117-b906-d169335441b2","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"d262f13b-ed13-541d-9ca8-e7075aebd557","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"089c38f6-7158-5d2f-9683-e1e16a2e7bc9","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"62a8100d-ffe9-5e3b-8ca4-071a242c2406","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"6dbc5aaa-df51-510a-af88-268983a5b382","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"81117569-d1c8-597d-a361-fa9822c7a4f7","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"18c68aea-1807-5bbb-a514-d9f773a881fb","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"8b19e056-04ae-54ca-b47a-de9d4ab8a63d","slug":"dosing-information","fullItemName":"Dosing information","depth":3,"htmlHeader":"<!-- begin field b7b5a5b4-9089-456b-8827-668aff0d516c --><h3>Dosing information</h3><!-- end field b7b5a5b4-9089-456b-8827-668aff0d516c -->","summary":"","htmlStringContent":"<!-- begin item 527152f4-81ed-421e-a7ba-9849da5458da --><!-- begin field cbaab197-107a-445a-8232-9ae97547f231 --><ul><li>Initially prescribe diazepam 2 mg up to three times a day when required to relieve muscle spasm. If necessary, the dose can be titrated up to 5 mg three times a day.<ul><li>A short course (2–5 days) is recommended because the risk of adverse effects is high, and habituation can occur.</li><li>Use caution if considering prescribing diazepam in elderly or frail people — the manufacturer advises halving the recommended dose.</li></ul></li></ul><h4>Diazepam withdrawal</h4><ul><li>If taken for a short period of time, diazepam can generally be stopped suddenly with few problems. However, withdrawal symptoms such as anxiety, depression, impaired concentration, insomnia, abdominal cramps, palpitations, and perceptual disturbances (such as hypersensitivity to physical, visual, and auditory stimuli) may occur.<ul><li>If withdrawal symptoms do occur, for information on how to manage them, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/benzodiazepine-z-drug-withdrawal/\">Benzodiazepine and z-drug withdrawal</a>.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/back-pain-low-without-radiculopathy/references/\">Taylor et al, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/back-pain-low-without-radiculopathy/references/\">ABPI Medicines Compendium, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/back-pain-low-without-radiculopathy/references/\">BNF 72, 2016</a>]</p><!-- end field cbaab197-107a-445a-8232-9ae97547f231 --><!-- end item 527152f4-81ed-421e-a7ba-9849da5458da -->","subChapters":[]},{"id":"4c61987f-9dc1-59ab-b744-012730e1e289","slug":"contraindications-cautions","fullItemName":"Contraindications and cautions","depth":3,"htmlHeader":"<!-- begin field 15d68334-0599-49a2-8670-57f59acd63ec --><h3>Contraindications and cautions</h3><!-- end field 15d68334-0599-49a2-8670-57f59acd63ec -->","summary":"","htmlStringContent":"<!-- begin item 1075c947-2458-487a-b579-9e6a09b3e529 --><!-- begin field 5a156f70-10c3-4a47-9431-a1dbdf50310f --><ul><li><strong>Do not prescribe diazepam to people with:</strong><ul><li>Current or a history of alcohol or opioid use or misuse — alcohol and opioids can induce lethal sedation by potentiating the effects of diazepam.</li><li>Acute porphyria.</li><li>Myasthenia gravis — condition may be aggravated.</li><li>Sleep apnoea — condition may be aggravated.</li><li>Bronchitis or chronic obstructive pulmonary disease.</li><li>Severe hepatic insufficiency — elimination half-life may be prolonged.</li><li>Major depression.</li><li>Phobic or obsessional states, psychosis or schizophrenia, hyperkinesis — paradoxical reactions may occur.</li></ul></li><li><strong>Prescribe diazepam with caution to:</strong><ul><li>People with personality disorders.</li><li>The elderly, due to the increased risk of falls — the manufacturer advises halving the recommended doses.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/back-pain-low-without-radiculopathy/references/\">ABPI Medicines Compendium, 2015</a>]</p><!-- end field 5a156f70-10c3-4a47-9431-a1dbdf50310f --><!-- end item 1075c947-2458-487a-b579-9e6a09b3e529 -->","subChapters":[]},{"id":"b09e65c2-58d0-51bd-9002-932889abf2f9","slug":"drug-interactions","fullItemName":"Drug interactions","depth":3,"htmlHeader":"<!-- begin field 7014e642-ec7d-4cb5-8bf3-c4c729d77b88 --><h3>Drug interactions</h3><!-- end field 7014e642-ec7d-4cb5-8bf3-c4c729d77b88 -->","summary":"","htmlStringContent":"<!-- begin item 5962efda-4ede-436a-a0c8-6de0560947c3 --><!-- begin field fe73af62-a0f8-4f04-967a-fec64e208b69 --><p><strong>Drug interactions with diazepam include:</strong></p><ul><li>Alcohol and opioids — advise against concomitant use with diazepam. Alcohol and opioids can induce lethal sedation by potentiating the effects of diazepam.</li><li>Antihypertensives, vasodilators, and diuretics — be aware that concomitant use with diazepam may enhance the hypotensive effects of these drugs.</li><li>Drugs that inhibit cytochrome P450 enzyme (for example cimetidine, ciprofloxacin, azole antifungals, and oestrogens) — avoid concomitant use with diazepam. The metabolism of diazepam is mediated by cytochrome P450 isoenzymes; concomitant use with P450 inhibitors can result in increased serum levels of diazepam leading to increased effect.</li><li>Drugs that induce cytochrome P450 enzyme (for example St John's Wort and rifampicin) — be aware that cytochrome P450 inducers can accelerate hepatic elimination of diazepam and decrease its action. Dose adjustment of diazepam may be needed.</li><li>HIV protease inhibitors (ritonavir and indinavir) — concomitant use with diazepam is contraindicated. The interactions between HIV protease inhibitors and benzodiazepines are variable; however, the manufacturers of ritonavir and indinavir advise that concurrent use with diazepam is contraindicated.</li><li>Modafinil — monitor for adverse effects of diazepam as modafinil may increase the effects of diazepam. Dose adjustments of diazepam may be needed.</li><li>Phenytoin — monitor phenytoin concentrations as concomitant use with diazepam may increase or decrease serum concentrations of phenytoin.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/back-pain-low-without-radiculopathy/references/\">ABPI Medicines Compendium, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/back-pain-low-without-radiculopathy/references/\">Preston, 2016</a>]</p><!-- end field fe73af62-a0f8-4f04-967a-fec64e208b69 --><!-- end item 5962efda-4ede-436a-a0c8-6de0560947c3 -->","subChapters":[]},{"id":"345eff05-f70f-5f22-84a5-303e5c7e09de","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field 85f75899-a731-442c-9de4-16b91c4449e2 --><h3>Adverse effects</h3><!-- end field 85f75899-a731-442c-9de4-16b91c4449e2 -->","summary":"","htmlStringContent":"<!-- begin item 3ee8a700-d704-4d99-96da-50b6891ac63b --><!-- begin field 83a2fa48-7412-49a0-9296-eafff1acaf1f --><ul><li><strong>The most common adverse effects of diazepam relate to its sedative effect </strong>and include drowsiness and decreased concentration. People who are taking benzodiazepines and who drive should, therefore be given the following advice:<ul><li>It is an offence to drive after taking diazepam if you feel drowsy, dizzy, unable to concentrate, or make decisions.</li><li>It is an offence to drive if you have more than a specified amount of benzodiazepine in your body, whether your driving is impaired or not.<ul><li>Roadside saliva screening tests in the UK detect certain drugs that impair driving. If you have a positive roadside drug test for benzodiazepines, the police may ask you to provide a blood sample to measure the amount of benzodiazepine in your body.</li><li>Even if you are found to have more than the specified amount of benzodiazepine in your body, as long as your driving is not impaired, and you are taking your medicine on the advice of a doctor or pharmacist, you will be able to raise a statutory 'medical defence' and the police may not prosecute you.</li><li>It may be helpful to keep evidence that you are taking a benzodiazepine in accordance with medical advice with you while you are driving. Suitable evidence may include: your medication box with the pharmacy label on, or the other half of your prescription with the list of medicines prescribed by your doctor.</li></ul></li></ul></li><li><strong>Other adverse effects include:</strong><ul><li>Headache, vertigo, tremor, slurred speech, decreased libido, erectile dysfunction, gynaecomastia, and obstructive sleep apnoea syndrome.</li><li>Paradoxical effects such as talkativeness, excitement, irritability, aggression, antisocial behaviour, and suicidal ideation.</li><li>Tolerance and dependence (these can develop over time).</li><li>Withdrawal syndrome — see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/benzodiazepine-z-drug-withdrawal/\">Benzodiazepine and z-drug withdrawal</a>.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/back-pain-low-without-radiculopathy/references/\">Sweetman, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/back-pain-low-without-radiculopathy/references/\">Taylor et al, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/back-pain-low-without-radiculopathy/references/\">ABPI Medicines Compendium, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/back-pain-low-without-radiculopathy/references/\">DVLA, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/back-pain-low-without-radiculopathy/references/\">BNF 72, 2016</a>]</p><!-- end field 83a2fa48-7412-49a0-9296-eafff1acaf1f --><!-- end item 3ee8a700-d704-4d99-96da-50b6891ac63b -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}